About this trial
The goal of this observational study is to evaluate the implementation of a structured, digital, nurse-led, remote monitoring care pathway for cardiovascular risk management (CVRM). Participants will receive this care as part of routine clinical practice. In addition to standard follow-up, participants will complete questionnaires on quality of life, medication adherence, system usability, and patient satisfaction.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age ≥18 years
All patients enrolled in the program (high-risk and very high-risk patients)
Disqualifiers
Not able to provide informed consent
No access to smartphone and/or tablet
Inability to use digital tools required for the program
Trial population
All patients enrolled in the digital CVRM program will be invited to participate in this registry.
Trial design
Cohort
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Number of patients on-target for LDL-c
Proportion of patients achieving guideline-recommended LDL-c targets
Secondary outcomes
Mean LDL-c
The mean of LDL-c values in mmol/L, measured at-home
Number of patients achieving blood pressure control
Proportion of patients achieving guideline-recommended blood pressure targets
Change in home-measured blood pressure values
Change in blood pressure values measured at home with telemonitoring in mmHg
Number of medication changes
Changes in lipid-lowering and antihypertensive medications, defined as change in dose and change in medication type
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Lead sponsor
Cardiology Centres of the Netherlands
Collaborator